Sun Hoe Koo

Sun Hoe Koo

Auto-generated profile, based on publicly available information

Sun Hoe Koo

Department of Laboratory Medicine, Chungnam National University Hospital, Daejeon, Korea

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Cancer Genetics and Cytogenetics
Verified
Journal Article
Closed access
JKJi Un Kang
Ji Un Kang
SKSun Hoe Koo
Sun Hoe Koo
KKKye Chul Kwon
Kye Chul Kwon
JPJong Woo Park
Jong Woo Park
JKJin Man Kim
Jin Man Kim

1 November 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
YKYeon-Sook Kim
Yeon-Sook Kim
HYHwan Jung Yun
Hwan Jung Yun
SSSoo Kyoung Shim
Soo Kyoung Shim
SKSun Hoe Koo
Sun Hoe Koo
SKS. Y. Kim
S. Y. Kim
SKS. Kim
S. Kim
Background. Scrub typhus is one of the most important endemic infections in the Asia-Pacific region. Although tetracyclines or chloramphenicol are the

9 December 2015 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
PDF file
JLJae Ho Lee
Jae Ho Lee
Bindu SubhadraBindu Subhadra
Bindu Subhadra
YSYeo‐Jin Son
Yeo‐Jin Son
DKDong Ho Kim
Dong Ho Kim
HPHo Sung Park
Ho Sung Park
CCChul Hee Choi
Chul Hee Choi

14 February 2017 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
JLJ.-K. Lee
J.-K. Lee
SLSandra Louzada
Sandra Louzada
YAY. An
Y. An
SKS. Y. Kim
S. Y. Kim
SKS. Kim
S. Kim
YJY. S. Ju
Y. S. Ju
Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare aggressive malignancy often occurring in the tissues of midline anatomical structures. Except for the pathognomonic BRD3/4–NUT rearrangement, the comprehensive landscape of genomic alterations in NMCs has been unexplored. We investigated three NMC cases, including two newly diagnosed NMC patients in Seoul National University Hospital, and a previously reported cell line (Ty-82). Whole-genome and transcriptome sequencing were carried out for these cases, and findings were validated by multiplex fluorescence in situ hybridization and using individual fluorescence probes. Here, we present the first integrative analysis of whole-genome sequencing, transcriptome sequencing and cytogenetic characterization of NUT midline carcinomas. By whole-genome sequencing, we identified a remarkably similar pattern of highly complex genomic rearrangements (previously denominated as chromoplexy) involving the BRD3/4–NUT oncogenic rearrangements in two newly diagnosed NMC cases. Transcriptome sequencing revealed that these complex rearrangements were transcribed as very simple BRD3/4–NUT fusion transcripts. In Ty-82 cells, we also identified a complex genomic rearrangement involving the BRD4–NUT rearrangement underlying the simple t(15;19) karyotype. Careful inspections of rearrangement breakpoints indicated that these rearrangements were likely attributable to single catastrophic events. Although the NMC genomes had >3000 somatic point mutations, canonical oncogenes or tumor suppressor genes were rarely affected, indicating that they were largely passenger events. Mutational signature analysis showed predominant molecular clock-like signatures in all three cases (accounting for 54%−75% of all base substitutions), suggesting that NMCs may arise from actively proliferating normal cells. Taken together, our findings suggest that a single catastrophic event in proliferating normal cells could be sufficient for neoplastic transformation into NMCs.

1 January 2013 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JKJimyung Kim
Jimyung Kim
M.M.D.
M.D.
SKSeong Wook Kang
Seong Wook Kang
JKJinhyun Kim
Jinhyun Kim
GKGyechul Kwon
Gyechul Kwon
SKSunhoe Koo
Sunhoe Koo
Jimyung Kim, M.D., Seongwook Kang, M.D., Jinhyun Kim, M.D., Gyechul Kwon, M.D., and Sunhoe Koo, M.D.. Ann Lab Med 2013;33:52-9. https://doi.org/10.3343/alm.2013.33.1.52

16 July 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JKJi Un Kang
Ji Un Kang
SKSun Hoe Koo
Sun Hoe Koo
KKKye Chul Kwon
Kye Chul Kwon
JPJong Woo Park
Jong Woo Park
JKJin Man Kim
Jin Man Kim
The underlying genetic alterations for squamous cell carcinoma (SCC) and adenocarcinoma (AC) carcinogenesis are largely unknown. High-resolution array- CGH was performed to identify the differences in the patterns of genomic imbalances between SCC and AC of non-small cell lung cancer (NSCLC). On a genome-wide profile, SCCs showed higher frequency of gains than ACs (p = 0.067). More specifically, statistically significant differences were observed across the histologic subtypes for gains at 2q14.2, 3q26.2–q29, 12p13.2–p13.33, and 19p13.3, as well as losses at 3p26.2–p26.3, 16p13.11, and 17p11.2 in SCC, and gains at 7q22.1 and losses at 15q22.2–q25.2 occurred in AC (P < 0.05). The most striking difference between SCC and AC was gains at the 3q26.2–q29, occurring in 86% (19/22) of SCCs, but in only 21% (3/14) of ACs. Many significant genes at the 3q26.2–q29 regions previously linked to a specific histology, such as EVI1,MDS1, PIK3CA and TP73L, were observed in SCC (P < 0.05). In addition, we identified the following possible target genes (> 30% of patients) at 3q26.2–q29: LOC389174 (3q26.2),KCNMB3 (3q26.32),EPHB3 (3q27.1), MASP1 and SST (3q27.3), LPP and FGF12 (3q28), and OPA1,KIAA022,LOC220729, LOC440996,LOC440997, and LOC440998 (3q29), all of which were significantly targeted in SCC (P < 0.05). Among these same genes, high-level amplifications were detected for the gene, EPHB3, at 3q27.1, and MASP1 and SST, at 3q27.3 (18, 18, and 14%, respectively). Quantitative real time PCR demonstrated array CGH detected potential candidate genes that were over expressed in SCCs. Using whole-genome array CGH, we have successfully identified significant differences and unique information of chromosomal signatures prevalent between the SCC and AC subtypes of NSCLC. The newly identified candidate target genes may prove to be highly attractive candidate molecular markers for the classification of NSCLC histologic subtypes, and could potentially contribute to the pathogenesis of the squamous cell carcinoma of the lung.